| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,127 |
6,964 |
$510K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
188 |
178 |
$76K |
| 94375 |
|
3,683 |
3,386 |
$73K |
| 99215 |
Prolong outpt/office vis |
555 |
434 |
$48K |
| 99407 |
|
2,510 |
2,114 |
$45K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
2,596 |
720 |
$35K |
| 99233 |
Prolong inpt eval add15 m |
1,605 |
373 |
$34K |
| 95811 |
|
82 |
80 |
$33K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,696 |
261 |
$18K |
| 94060 |
|
706 |
659 |
$16K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
88 |
85 |
$15K |
| 94729 |
|
588 |
554 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
135 |
126 |
$6K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
68 |
25 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
303 |
205 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
154 |
94 |
$5K |
| 94660 |
|
207 |
198 |
$5K |
| 94726 |
|
263 |
244 |
$4K |
| 99401 |
|
73 |
60 |
$2K |
| 94618 |
|
95 |
89 |
$2K |
| 94664 |
|
116 |
111 |
$562.66 |
| 95117 |
|
62 |
27 |
$246.43 |
| 94762 |
|
14 |
12 |
$234.42 |
| 99222 |
Initial hospital care, per day, moderate complexity |
13 |
12 |
$215.10 |
| 99091 |
|
43 |
43 |
$203.40 |
| 71046 |
Radiologic examination, chest; 2 views |
14 |
12 |
$176.53 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
35 |
12 |
$156.89 |
| 94727 |
|
17 |
16 |
$148.68 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
26 |
16 |
$36.67 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
519 |
479 |
$27.03 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
18 |
15 |
$0.00 |